GET DAILY SIGNALSHealth In Tech (HIT) Q3 Results: Revenue Declines 22.4% as Strategic Pivot Continues
Key Takeaways
- Total revenue fell 22.4% year over year to $6.59 million in the third quarter of 2026, down from $8.49 million a year earlier.
- Health In Tech swung to a net loss of $7.1 million, or $0.11 per share, versus net income of $0.45 million, or $0.01 per share, in the prior-year quarter.
- A $5.3 million provision for credit losses was the primary driver of the quarterly loss.
- Gross margin compressed to 46.5% from 60.6% as the company absorbed higher third-party service costs tied to its new self-funded plan offering.
- Management lowered its full-year 2026 revenue outlook to roughly $30 million, modestly below 2025 revenue.
Why This Quarter Matters
Health In Tech, Inc. operates an AI-enabled InsurTech platform that connects insurance carriers, licensed brokers, managing general underwriters (MGUs), and third-party administrators (TPAs) around self-funded employer health plans. The third-quarter results are significant because they reflect a deliberate shift in the business. The company has been investing in sales, distribution, and a new end-to-end self-funded administration service. This quarter’s revenue drop and larger loss provide a test of whether that approach can convert contracted demand into recognized revenue and, over time, profitability. With the stock trading well below its 52-week high, I’m watching closely for indications that the investment is starting to deliver.
The Quarter’s Numbers in Detail
For the three months ended September 30, 2026, Health In Tech (HIT) reported total revenue of $6.59 million, a 22.4% decline from $8.49 million in the same period a year earlier and slightly below consensus estimates near $6.9 million. Fee revenue from its Stone Mountain Risk (SMR) program manager fell to $5.95 million from $7.10 million, while underwriting modeling revenue from its International Captive Exchange (ICE) unit dropped to $0.63 million from $1.39 million.
The company posted a net loss of $7.1 million, or $0.11 per diluted share, compared with net income of $0.45 million, or $0.01 per share, a year ago. The loss per share was wider than the roughly $0.05 loss analysts had modeled. The shortfall was driven largely by a $5.3 million provision for credit losses, including write-downs of receivables and a foreign loan receivable. Gross profit declined to $3.06 million, pushing gross margin down to 46.5% from 60.6%, while adjusted EBITDA turned negative at about negative $3.9 million versus positive $1.0 million a year earlier. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Market Reaction and Sentiment
Investors responded cautiously to the results. Shares closed the regular session down 4.33% at $0.5353 and slipped further in after-hours trading, reflecting concern over the sharp revenue decline and the sizable credit-loss charge. The company’s earlier disclosure that it was revising its full-year revenue outlook to roughly $30 million, well below its prior guidance of $45 million to $50 million, had already pressured sentiment. The combination of a wider-than-expected loss and a trimmed forecast reinforced near-term caution even as management pointed to a growing distribution network and pipeline as evidence of underlying demand.
What to Watch Going Forward
The central question for investors is whether Health In Tech (HIT) can convert its growing book of business into recognized revenue without further balance-sheet damage. Management cited slower onboarding of new carrier partners and delays in converting quotes into contracted revenue as key timing issues, and it has pointed to a $150 million backlog as a foundation for renewed growth in 2027.
Several factors will shape the outlook. First, watch gross margin trajectory: the new self-funded administration service carries higher third-party costs, and margins need to stabilize. Second, monitor credit quality and receivables, given the $5.3 million provision this quarter and the company’s customer concentration with a single stop-loss carrier. Third, track the distribution partner count, which rose to 984 from 849 a year earlier, as a leading indicator of future volume.
Finally, pay attention to cash and liquidity. The company ended the quarter with about $10.1 million in cash, and the pace of operating cash burn, though improving sequentially, remains a key constraint. Guidance, product launches such as the HitRix AI platform, and any new carrier partnerships will be important catalysts in the quarters ahead.
My Experience with Tickeron’s AI Tools
In my own research on names like this, I often turn to Tickeron’s AI Screener to quickly filter for comparable companies and spot patterns in revenue trends or margin pressure. The tool has helped me cross-check fundamentals against peers and surface potential setups more efficiently than manual methods. It’s become a regular part of how I evaluate quarterly results and build context around earnings releases.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
Momentum Indicator for HIT turns negative, indicating new downward trend
HIT saw its Momentum Indicator move below the 0 level on November 11, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator turned negative. In 30 of the 31 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where HIT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 89%.
The Aroon Indicator for HIT entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where HIT's RSI Oscillator exited the oversold zone, 5 of 7 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 16 of 20 cases where HIT's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 80%.
The Moving Average Convergence Divergence (MACD) for HIT just turned positive on October 28, 2026. Looking at past instances where HIT's MACD turned positive, the stock continued to rise in 9 of 11 cases over the following month. The odds of a continued upward trend are 82%.
Following a +21.27% 3-day Advance, the price is estimated to grow further. Considering data from situations where HIT advanced for three days, in 76 of 90 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.
HIT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 20 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.856) is normal, around the industry mean (-1.906). P/E Ratio (-7.926) is within average values for comparable stocks, (9.554). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.824). Dividend Yield (0.000) settles around the average of (0.069) among similar stocks. P/S Ratio (1.535) is also within normal values, averaging (70.383).
The Tickeron Price Growth Rating for this company is 86 (best 1 - 100 worst), indicating slightly worse than average price growth. HIT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 98 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HIT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry PackagedSoftware
Advertisement